Personalized medicine puts a new face on drug research

02/7/2013 | Wall Street Journal, The

Drugmakers increasingly use genetic data to select for early-stage clinical trials patients who are likely to benefit from the experimental drug. The strategy could reduce the time it takes to get a new drug approved with less money wasted on ineffective trials, experts say.

View Full Article in:

Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC